Donate
T1International Names Nicole Smith-Holt Ambassador

T1International Names Nicole Smith-Holt Ambassador

Facebook Google LinkedIn Twitter

T1International is proud and honoured to announce that Nicole Smith-Holt has accepted our invitation to serve as T1International Ambassador.

If you have not yet heard of Nicole or her advocacy on behalf of her son Alec, she’s someone you need to know. After Alec died in 2017 from rationing his insulin, Nicole began speaking out about the need for true solutions to the insulin affordability crisis. Since learning about us, she has been a strong supporter of T1International. Along with other #insulin4all advocates, we have worked closely with her to support her advocacy and provide resources, information, and a platform in our joint fight for affordable and accessible insulin and supplies for everyone.

In 2018 alone, Nicole has done over 50 media appearances, interviews, and news features to share Alec’s story and to highlight the need for affordable insulin and the patient advocacy movement that is leading the charge.

Below is a short interview with Nicole to highlight her top experiences, biggest challenges, and what she’s most looking forward to in the future. We cannot thank Nicole (and her family) enough for her tireless, poised and determined voice, and we are thrilled to have her as our Ambassador.

1. What are you most proud of doing in 2018 to advocate for affordable insulin?

My top experiences with my advocacy to date are:

  • Participating in the various rallies outside the insulin companies
  • Meeting so many passionate advocates from all over the world
  • Testifying at the Senate hearing in DC on prescription drug prices
  • Filming a PBS documentary on insulin prices and the advocacy surrounding our fight for affordable insulin
  • Working side-by-side with state and federal legislatures on drug pricing bills
  • Being featured by Bernie Sanders!

2. What has been hardest/most frustrating about doing what you do?

The hardest part of my experience as an advocate is reading all the negative comments surrounding my son’s death. I so often see things like, ‘’Why didn't he do this?’’, ‘’Why didn't he do that?’’ I also find it extremely frustrating that there’s such a huge lack of knowledge about type 1 and type 2 diabetes. I find myself constantly trying to educate people on the difference and explaining that no diet, pill, or special herb could have kept him alive.

3. Why do you like about working with T1International?

I love working with T1International because the advocates that are involved with this cause are so knowledgeable, so passionate, and so driven. It is amazing to have them to fall back on. I like the fact that T1International accepts no funding from the pharmaceutical or device industry. They are simply a grassroots organization that has a #1 priority, which is the lives of people with diabetes, so they focus on advocating for affordable and accessible insulin and supplies for all. T1International feels like a family.

4. What are you most looking forward to for the future with this movement?

I look forward to the day that people with diabetes are able to purchase their insulin and supplies without worry of cost. I look forward to the day when no one with diabetes worries about compilations or death as a result of not being able to afford insulin. I look forward to a day when I no longer need to stand before a room of our elected officials and retell the story of my son’s death. I look forward to a day when insulin insecurity no longer exists anywhere.

We couldn’t agree more with Nicole, and T1International will continue to fight with her until that is a true reality.

Related posts:

T1International, Minnesota #insulin4all, and Partners Submit Amicus Brief for Alec Smith Bill

T1International, Minnesota #insulin4all, and Partners Submit Amicus Brief for Alec Smith Bill

There is an insulin rationing crisis in the United States, driven by the high price of this life-saving medication. Research indicates that one-quarter of people with diabetes have to ration their insulin because of the cost, and rationing puts patients at greater risk of health complications, including death. In Minnesota, advocates responded to the deaths of Alec Raeshawn Smith and Jesimya David Scherer-Radcliff by fighting to pass the Alec Smith Insulin Affordability Act, which was the first in the nation to establish a program for patients with diabetes to purchase the insulin they need at an affordable price. After years of work, this bill was signed into law by Governor Tim Walz on April 15, 2020. Read more

Losing Meaghan to the Perfect Storm

Losing Meaghan to the Perfect Storm

The perfect storm does not warn you that it will be different than any other you have weathered. On top of her other worries, the company that produced the insulin pump Meaghan was using had recently gone out of business. Without a job or insurance, it was impossible to purchase supplies, much less a different pump. At the time, Meaghan had two short term jobs but had not had them long enough to get insurance. She had another job lined up to start the week after Christmas and she would have been okay. She wasn't.
Read more

Nicole Smith-Holt Statement on Eli Lilly Helpline Announcement

Nicole Smith-Holt Statement on Eli Lilly Helpline Announcement

I vow to continue to fight for the rights and lives of all people with diabetes. I am doing all this in honor of my son, Alec Raeshawn Smith. I invite Lilly to work with me and non-industry funded organizations like T1International so that we can find real solutions to ensure #insulin4all. Mr. Mason, I am still waiting to hear from you. Read more

My Journey to Eli Lilly HQ for Answers

My Journey to Eli Lilly HQ for Answers

I was very nervous before going to confront the top executives of Eli Lilly and Company. But I was determined to tell them Alec’s story. They needed to hear from me what their insulin prices did to Alec, and are still doing to others. Read more

Eli Lilly and Novo Nordisk: More Empty Promises

Eli Lilly and Novo Nordisk: More Empty Promises

Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more